ELI-002
Elicio Therapeutics
['rectal', 'colorectal', 'pancreatic', 'elicio', 'elicio,(-delicious)']
$eltx new article : elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal cancer at the asco annual meeting 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.